B Cell News and Research

RSS
PerkinElmer Completes Acquisition of Antibody and Reagent Leader BioLegend

PerkinElmer Completes Acquisition of Antibody and Reagent Leader BioLegend

Repeated injury to the epithelial tissue of airways causes "biological aging" of stem cells

Repeated injury to the epithelial tissue of airways causes "biological aging" of stem cells

Researchers seek to identify the role of hypoxia on red blood cell aging

Researchers seek to identify the role of hypoxia on red blood cell aging

Compound extracted from orchid could be a potential treatment option for prostate cancer

Compound extracted from orchid could be a potential treatment option for prostate cancer

Study findings could lead to novel ways to overcome tumor resistance to immunotherapies

Study findings could lead to novel ways to overcome tumor resistance to immunotherapies

Study supports the implementation of Beckman Coulter’s MDW in emergency labs as initial test to detect sepsis

Study supports the implementation of Beckman Coulter’s MDW in emergency labs as initial test to detect sepsis

Discovery of genes opens the door to new treatments for obesity

Discovery of genes opens the door to new treatments for obesity

Research pinpoints new therapeutic opportunity for ovarian clear cell carcinomas

Research pinpoints new therapeutic opportunity for ovarian clear cell carcinomas

Scientists use statistical mechanics to make sense of DNA folding

Scientists use statistical mechanics to make sense of DNA folding

COVID-19 deaths in U.S. surpass 1918 Spanish Flu pandemic

COVID-19 deaths in U.S. surpass 1918 Spanish Flu pandemic

Revival of the cell and gene therapy field opens new avenues for repairing the Parkinsonian brain

Revival of the cell and gene therapy field opens new avenues for repairing the Parkinsonian brain

Nemours receives $10.5 million NIH grant to support research in sickle cell disease

Nemours receives $10.5 million NIH grant to support research in sickle cell disease

Those undergoing treatment for hematological malignancies show reduced immune response to COVID-19 vaccines

Those undergoing treatment for hematological malignancies show reduced immune response to COVID-19 vaccines

Oxford COVID vaccine technology has the potential to revolutionize cancer treatment

Oxford COVID vaccine technology has the potential to revolutionize cancer treatment

Implications of dosing sparing and booster shots in the context of prior SARS-CoV-2 infection

Implications of dosing sparing and booster shots in the context of prior SARS-CoV-2 infection

Comparison of recombinant SARS-CoV-2 receptor binding domain produced in mammalian, insect, and bacterial cells

Comparison of recombinant SARS-CoV-2 receptor binding domain produced in mammalian, insect, and bacterial cells

Researchers create a living bioengineered nerve circuit to tackle opioid overdose crisis

Researchers create a living bioengineered nerve circuit to tackle opioid overdose crisis

Study paves the way for development of novel delivery systems to suppress HIV

Study paves the way for development of novel delivery systems to suppress HIV

Researchers provide structural insights into HCV receptor binding and entry

Researchers provide structural insights into HCV receptor binding and entry

KU researcher wins $1.25 million award to investigate the vital role of sex hormones in tissue repair

KU researcher wins $1.25 million award to investigate the vital role of sex hormones in tissue repair

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.